Overpatented, Overpriced: Tackling the Root of the Drug Pricing Crisis

[Initiative for Medicines, Access and Knowledge (I-MAK)] The patent system is not working as intended and the public is paying the price. Astronomical prescription drug costs are straining the healthcare system and the budgets of American families and employers. Prescription drug spending has increased 60% in the last decade to over $400 billion today. The status quo is unsustainable.